Jeffrey Bluestone Talks About Immune Rejection of Stem Cell-Based Therapies

Jack Hubbard

Any cells derived from embryonic stem cells that are transplanted as a therapy will likely be rejected by the immune system much like a transplanted heart or liver. Dr. Jeffrey Bluestone has been studying ways of achieving transplantation with little or no drugs. He is the A.W. & Mary Margaret Clausen Distinguished Professor of Medicine, Pathology, Microbiology & Immunology, Interim Associate Vice Chancellor, Research, Director of the Immune Tolerance Network, and is a member of the UCSF Institute for Regeneration Medicine.

Disease Programs

Learn about how stem cell research could generate the therapies for many chronic diseases and injuries

See disease fact sheets

CIRM Stem Cell Blog